Get the Stockscreener App
107.19
0.18%
+0.19
Why is Blueprint Medicines Corp (BPMC) Stock down?
We've noticed a 5.42% decline in Blueprint Medicines Corp (BPMC) stock during the 2024-04-12 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
02 Aug, 2023:
Shares of Blueprint Medicines (BPMC) were down more than 15.34% to $54.30 on Wednesday after the healthcare company announced second-quarter earnings. While the numbers were generally positive, investors are likely to sell on good news, taking advantage of a positive announcement, but the selling got out of hand.
https://www.fool.com/investing/2023/08/02/why-shares-of-blueprint-medicines-are-falling-wedn/
1.62%
0.15%
Cap:
|
Volume (24h):